Evidence map›Paper›PMID 27559144›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2016

Multiple Functions of Protein Inhibitor of Activated STAT1 in Regulating Endothelial Cell Proliferation and Inflammation.

Jun-Ichi Abe

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Jun-Ichi AbeFrom the Department of Cardiology, University of Texas MD Anderson Cancer Center, Houston. jabe@mdanderson.org.

Funding

PAR 13-233 cART accelerates vascular aging in HIV infected subjectsR01HL123346 · NHLBI · UNIVERSITY OF ROCHESTER · PI ABE, JUN-ICHI, MAGGIRWAR, SANJAY B. · 2014 to 2018
$3.7M
Disturbed flow-induced TERF2IP post-translational modifications and atherosclerosis.R01HL130193 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ABE, JUN-ICHI · 2016 to 2019
$2.0M
p90RSK-ERK5 module, efferocytosis, and vulnerable plaque formationR01HL118462 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ABE, JUN-ICHI · 2014 to 2018
$2.0M
Ubiquitin-like protein modification in diabetic cardiomyopathyR01HL108551 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ABE, JUN-ICHI, YANG, JAY · 2011 to 2014
$1.6M
NHLBI NIH HHS R01 HL108551NHLBI NIH HHS R01 HL118462NHLBI NIH HHS R01 HL123346NHLBI NIH HHS R01 HL130193
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

InflammationSTAT1 Transcription FactorCell ProliferationHumansProtein Inhibitors of Activated STATProtein Inhibitors of Activated STATSTAT1 protein, humanSTAT1 Transcription Factorendothelial cell proliferationPIAS1STAT1SUMO E3 ligasetransrepression

Identifiers

PMID27559144
PMCPMC5147510

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.